Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

Viatris

Status and phase: Completed; Phase 3

Conditions: Pulmonary Hypertension

Treatments: Drug: Sildenafil citrate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00159887

A1481142

Details and patient eligibility

About

Open label extension study to the pivotal efficacy study to assess the safety of sildenafil citrate in patients with pulmonary arterial hypertension

Enrollment: 260 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with PAH who had completed the 12 week pivotal study

Exclusion criteria

• Any other patients with PAH that had not been included into the pivotal study

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)